LD-2 disclosure · 2nd Quarter - Report
ABBOTT LABORATORIES
Client
- Location
- District of Columbia · United States of America
Registrant
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
6 issuesConsumer Issues/Safety/Products
Proposals related to data privacy/data collection, usage and retention.
LobbyistsTHOMAS EVERS · AUSTIN BURNES · JENNIFER BARBLAN
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. H.R. 2369 Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023. Proposals related to sterilization of medical devices. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR). Proposals related to Department of Defense coverage of continuous glucose monitors. Proposals related to future pandemic preparedness. Proposals related to the safe manufacturing of medical devices. Proposals related to telehealth implementation and remote monitoring. Proposals related to the use of diagnostic tests in CLIA-waived settings. Proposals related to federal workforce drug testing programs. Proposals related to medical device cybersecurity.
LobbyistsTHOMAS EVERS · AUSTIN BURNES · SETH M RADUS · DEVON NICOLE FOLTZ · JENNIFER BARBLAN · ROSALYN KUMAR
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · White House Office · Health & Human Services, Dept of (HHS)
Medicare/Medicaid
S. 1000/H.R. 1835 Saving Access to Laboratory Services Act. Proposals regarding PAMA regulations and changes to modernize and update the Clinical Laboratory Fee Schedule. Proposals related to Medicare coverage of continuous glucose monitors.
